Bridging the fields of engineering and psychiatry, this dissertation proposes a novel framework for the rational dosing of electric and magnetic seizure therapy, including electroconvulsive therapy (ECT) and magnetic seizure therapy (MST), for the treatment of psychiatric disorders such as medication resistant major depression and schizophrenia. The objective of this dissertation is to develop computational modeling tools that allow ECT and MST stimulation paradigms to be biophysically optimized ex vivo, prior to testing safety and efficacy in preclinical and clinical trials. Despite therapeutic advances, treatment resistant depression (TRD) remains a largely unmet clinical need. ECT is highly effective for TRD, but its side effects limit its real-world clinical utility. Modifications of treatment technique (e.g., electrode placement, stimulus parameters, novel paradigms such as MST) significantly improve the tolerability of convulsive therapy. However, we know relatively little about the distribution of the electric field (E-field) induced in the brain to inform spatial targeting of ECT and MST. Lacking an understanding of biophysical and physiological mechanisms, refinements in ECT/MST technique rely exclusively on time-consuming and costly clinical trials. Consequently, key questions remain unanswered about how to position the ECT electrodes or MST coil for targeted brain stimulation. Addressing this knowledge gap, this dissertation proposes a new platform that will inform an improved spatial targeting of ECT and MST through state-of-the-art computer simulations of the E-field distribution in human and nonhuman primate (NHP) brain. Part I of this dissertation aims to develop anatomically realistic finite element models of transcranial electric and magnetic stimulation in human and NHPs incorporating tissue heterogeneity and anisotropy derived from structural magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) data. The NHP models of ECT and MST are created alongside the human model since NHPs are used in preclinical studies on the mechanisms of seizure therapy. Part II of this dissertation aims to apply the model developed in Part I to electric and magnetic seizure therapy. We compute the strength and spatial distributions of the E-field induced in the brain by various ECT and MST paradigms. The relative E-field strength among various regions of interest (ROIs) is examined to select electrode/coil configurations that produce most focal stimulation of target ROIs that are considered to mediate the therapeutic action of ECT and MST. Since E-field alone is insufficient to account for individual differences in neurophysiological response, we calibrate the E-field maps relative to the neural activation threshold via in vivo measurements of the corticospinal tract response to single pulses (motor threshold, MT). We derive an empirical estimate of the neural activation threshold by coupling simulated E-field strength with individually measured MT. The E-field strength relative to an empirical neural activation threshold and corresponding volume of suprathreshold stimulation (focality) is examined to inform the selection of ECT and MST stimulus pulse amplitude that will result in focal ROI stimulation. We contrast the ECT/MST stimulation strength and focality with conventional fixed and individually titrated pulse amplitude necessary to induce a seizure (seizure threshold, ST) to study pulse amplitude adjustment as a novel means of controlling stimulation strength and focality. This work provides a basis for rational dosing of seizure therapies that could help improve their risk/benefit ratio and guide the development of safer alternatives for patients with severe psychiatric disorders.

Submitted by Carvalho Dias João Paulo (joao.dias@famerp.br) on 2018-04-12T17:42:05Z No. of bitstreams: 1 karinakellyborges_tese.pdf: 4166303 bytes, checksum: 6285f0b896e90ee79617143e2fd72af2 (MD5) / Made available in DSpace on 2018-04-12T17:42:05Z (GMT). No. of bitstreams: 1 karinakellyborges_tese.pdf: 4166303 bytes, checksum: 6285f0b896e90ee79617143e2fd72af2 (MD5) Previous issue date: 2016-11-24 / Introduction: Parkinson's disease (PD) is a chronic progressive disease that affects physical, cognitive and emotional aspects. Objective: The aim of this study was to evaluate the occurrence of changes in cognition and symptoms of mental disorders pre and post implant DBS (Deep Brain Stimulation) through a Neuropsychological Assessment (NA). Casuistics and Method: This is a descriptive study in which patients with PD, candidates and submitted to implantation of DBS have participated. NA was performed in these patients before and after implantation of DBS with the following instruments: Wechsler Adult Intelligence Scale; Trail Making Test - Form A and B; Stroop Test; Boston Naming Test; Hooper Visual Organization Test; Wechsler Memory Scale-Revised (WMS-R); Rey Complex Figure; Rey Auditory Verbal Learning Test (RAVLT); Wisconsin Card Sorting Test (WCST) and Beck´s Depression and Anxiety Inventory . Results: From the 29 patients evaluated; the mean age was 60.2 (± 9.35) years , mainly males (n = 19), married (n = 21), with complete primary education (n = 22) and retired ( n = 24). The average time of diagnosis was 11.37 years (± 5.47), the mean age of onset 48.63 (± 7.36). The stage of PD was light to moderate. Clinical evaluation showed significant differences pre and post DBS, with improvement in symptoms. The NA has identified improvement after DBS overall intelligence quotient (p = 0.0022), in activities related to processing speed, and symptoms of mental disorders: depression (p <0.0001), anxiety (p = 0.0038) and apathy (p <0.001). Worsening after DBS was Identified in executive function, memory and verbal fluency. Conclusions: After DBS implantation, there was improvement in symptoms of depression, anxiety and apathy. In general, there was no improvement in cognitive function. / Introdução: Doença de Parkinson (DP) é uma doença crônica progressiva, que compromete aspectos físicos, cognitivos e emocionais. Objetivo: O objetivo deste estudo foi avaliar a ocorrência de alterações na cognição e nos sintomas de transtornos mentais pré e pós implante de DBS (Deep Brain Stimulation) por meio de uma avaliação neuropsicológica (AN). Casuística e Método: Estudo descritivo, no qual participaram pacientes com DP, candidatos e submetidos ao implante de DBS. Foi realizada AN nos pacientes pré e pós implante de DBS com os seguintes instrumentos: Wechsler Adult Intelligence Scale; Trail Making Test - Forma A e B; Stroop Test; Boston Naming Test; Hooper Visual Organization Test; Wechsler Memory Scale- Revised (WMS-R); Figura Complexa de Rey; Rey Auditory Verbal Learning Test (RAVLT); Wisconsin Cards Sorting Test (WCST) e Escalas de Depressão e de Ansiedade de Beck. Resultados: Dos 29 pacientes avaliados, a média de idade foi 60,2 (± 9,35) anos, eram principalmente do sexo masculino (n=19), casados (n=21), com ensino fundamental completo (n=22) e aposentados (n=24). O tempo médio de diagnóstico da doença foi 11,37 anos (± 5,47), a média de idade de início 48,63 (± 7,36). O estágio da DP era leve a moderado. A avaliação clínica indicou diferença significante pré e pós DBS, com melhora dos sintomas. A AN identificou melhora pós DBS no quociente intelectual geral (p=0,0022), nas atividades relacionadas à velocidade de processamento, e nos sintomas de transtornos mentais: depressão (p<0,0001), ansiedade (p=0,0038) e apatia (p<0,001). Identificou piora pós DBS na função executiva, memória e fluência verbal. Conclusões: Após o implante de DBS houve melhora dos sintomas de depressão, ansiedade e apatia. Não houve melhora da função cognitiva em geral.

Atualmente se tem bem estabelecido o tratamento para Doença de Parkinson, dentre eles o DBS (Deep Brain Stimulation). Embora haja controvérsias, muitos estudos têm demonstrado os efeitos adversos do DBS sobre a cognição, humor e comportamento. Assim, este estudo buscou investigar a associação entre os prejuízos cognitivos no pós-operatório e a volumetria cerebral em pacientes parkinsonianos submetidos a DBS, verificando se a correlação entre ambos pode ser considerada fator de risco para os prejuízos encontrados no pós-operatório. Fizeram parte da população estudada 25 indivíduos, 80% do sexo masculino, que foram submetidos ao procedimento cirúrgico de estimulação cerebral profunda (DBS) no Hospital de Clínicas de Porto Alegre (HCPA), em Porto Alegre entre 2012 e 2015. Estes sujeitos foram submetidos a uma bateria de testes cognitivos, bem como a testes clínicos e a ressonância magnética computadorizada nos períodos pré e pós-operatório em 6 meses. Os dados foram analisados através de estatísticas descritivas, coeficiente de correlação de Pearson e Teste t. Os resultados serão considerados significativos a um nível de significância máximo de 5% (p≤ 0,05) e o software estatístico utilizado para a análise será o SPSS versão 20.0. Quanto aos aspectos cognitivos avaliados, somente a fluência verbal fonêmica mostrou redução significativa entre os períodos pré e pós-operatório (p=0,003). A transfixação dos ventrículos foi associada à perda na fluência verbal semântica (p=0,009) e na memória (p=0,016) no pós-operatório. A presença de lesão na substância branca foi associada ao maior prejuízo na função executiva (p=0,017), fluência verbal semântica (p=0,039) e memória (p=0,050). Conclusão: Os prejuízos na fluência verbal semântica e memória no pós-operatório foram associados à presença de lesão na substância branca e a transfixação dos ventrículos pelo cabo com 6 eletrodos. A perda na função executiva foi associada a presença de lesão na substância branca. Os danos na fluência verbal fonêmica no pós-operatório, embora difiram estatisticamente, não foram associados a quaisquer achados da RM. / Currently, the treatment for Parkinson's Disease has been well established, among them DBS (Deep Brain Stimulation). Although controversial, many studies have demonstrated the adverse effects of DBS on cognition, mood, and behavior. Thus, this study sought to investigate the association between cognitive impairment in the postoperative period and cerebral volume in patients with Parkinson's disease who underwent DBS, and whether the correlation between the two can be considered as a risk factor for the possible postoperative losses. Twenty-five subjects, 80% male, who underwent deep brain stimulation (DBS) at the Hospital de Clínicas in Porto Alegre, Porto Alegre, between 2012 and 2015, were submitted to a cognitive battery, as well as clinical trials and computerized magnetic resonance imaging in the preoperative and postoperative periods at 6 months. Data were analyzed through descriptive statistics, Pearson's correlation coefficient and t-test. The results will be considered significant at a maximum significance level of 5% (p≤0.05) and the statistical software used for analysis will be SPSS version 20.0. Concerning the cognitive aspects evaluated, only phonemic verbal fluency showed a significant reduction between the pre and postoperative periods (p = 0.003). The transfixation of the ventricles was associated with loss of semantic verbal fluency (p = 0.009) and memory (p = 0.016) in the postoperative period. The presence of lesion in the white matter was associated with greater impairment in executive function (p = 0.017), semantic verbal fluency (p = 0.039) and memory (p = 0.050). Conclusion: The losses in the semantic verbal fluency and memory in the postoperative period were associated with the presence of white matter lesion and the transfixation of the ventricles by the cable with electrodes. The loss of executive function was associated with the presence of injury in the white matter. Damage to phonemic verbal fluency in 8 the postoperative period, although statistically different, was not associated with any MRI findings.

Atualmente se tem bem estabelecido o tratamento para Doença de Parkinson, dentre eles o DBS (Deep Brain Stimulation). Embora haja controvérsias, muitos estudos têm demonstrado os efeitos adversos do DBS sobre a cognição, humor e comportamento. Assim, este estudo buscou investigar a associação entre os prejuízos cognitivos no pós-operatório e a volumetria cerebral em pacientes parkinsonianos submetidos a DBS, verificando se a correlação entre ambos pode ser considerada fator de risco para os prejuízos encontrados no pós-operatório. Fizeram parte da população estudada 25 indivíduos, 80% do sexo masculino, que foram submetidos ao procedimento cirúrgico de estimulação cerebral profunda (DBS) no Hospital de Clínicas de Porto Alegre (HCPA), em Porto Alegre entre 2012 e 2015. Estes sujeitos foram submetidos a uma bateria de testes cognitivos, bem como a testes clínicos e a ressonância magnética computadorizada nos períodos pré e pós-operatório em 6 meses. Os dados foram analisados através de estatísticas descritivas, coeficiente de correlação de Pearson e Teste t. Os resultados serão considerados significativos a um nível de significância máximo de 5% (p≤ 0,05) e o software estatístico utilizado para a análise será o SPSS versão 20.0. Quanto aos aspectos cognitivos avaliados, somente a fluência verbal fonêmica mostrou redução significativa entre os períodos pré e pós-operatório (p=0,003). A transfixação dos ventrículos foi associada à perda na fluência verbal semântica (p=0,009) e na memória (p=0,016) no pós-operatório. A presença de lesão na substância branca foi associada ao maior prejuízo na função executiva (p=0,017), fluência verbal semântica (p=0,039) e memória (p=0,050). Conclusão: Os prejuízos na fluência verbal semântica e memória no pós-operatório foram associados à presença de lesão na substância branca e a transfixação dos ventrículos pelo cabo com 6 eletrodos. A perda na função executiva foi associada a presença de lesão na substância branca. Os danos na fluência verbal fonêmica no pós-operatório, embora difiram estatisticamente, não foram associados a quaisquer achados da RM. / Currently, the treatment for Parkinson's Disease has been well established, among them DBS (Deep Brain Stimulation). Although controversial, many studies have demonstrated the adverse effects of DBS on cognition, mood, and behavior. Thus, this study sought to investigate the association between cognitive impairment in the postoperative period and cerebral volume in patients with Parkinson's disease who underwent DBS, and whether the correlation between the two can be considered as a risk factor for the possible postoperative losses. Twenty-five subjects, 80% male, who underwent deep brain stimulation (DBS) at the Hospital de Clínicas in Porto Alegre, Porto Alegre, between 2012 and 2015, were submitted to a cognitive battery, as well as clinical trials and computerized magnetic resonance imaging in the preoperative and postoperative periods at 6 months. Data were analyzed through descriptive statistics, Pearson's correlation coefficient and t-test. The results will be considered significant at a maximum significance level of 5% (p≤0.05) and the statistical software used for analysis will be SPSS version 20.0. Concerning the cognitive aspects evaluated, only phonemic verbal fluency showed a significant reduction between the pre and postoperative periods (p = 0.003). The transfixation of the ventricles was associated with loss of semantic verbal fluency (p = 0.009) and memory (p = 0.016) in the postoperative period. The presence of lesion in the white matter was associated with greater impairment in executive function (p = 0.017), semantic verbal fluency (p = 0.039) and memory (p = 0.050). Conclusion: The losses in the semantic verbal fluency and memory in the postoperative period were associated with the presence of white matter lesion and the transfixation of the ventricles by the cable with electrodes. The loss of executive function was associated with the presence of injury in the white matter. Damage to phonemic verbal fluency in 8 the postoperative period, although statistically different, was not associated with any MRI findings.

With increasing life expectancy and global population of older adults, preserving cog- nitive function throughout life represents a growing priority. Numerous approaches to cognitive enhancement exist, but few have scientific merit. Among the most preva- lent – and commercialized – approaches are cognitive training (“brain training”) and non-invasive brain stimulation through electric currents applied at the surface of the scalp. The present dissertation describes a collection of work contextualizing the appeal of these cognitive enhancement methods and addressing some of the most pervasive limitations of research in this field thus far. One largely ignored issue in cognitive intervention research pertains to people’s expectations of programs and their relationship with intervention outcomes. In a series of initial studies, we developed and validated the Expectation Assessment Scale (EAS), a tool created to measure as well as prime expectations of outcomes in the context of cognitive enhancement interventions. In our first two studies, we probed expectations of cognitive training or non-invasive brain stimulation in over 1,000 young, middle-aged, and older adults. Ratings on the EAS suggested that older adults may have particularly high expectations of cognitive training, but that expectations can be primed to increase or decrease – at least in hypothetical scenarios. We used these data to assess the psychometric properties of the EAS with item-response theory, and confirmed its internal consistency. Next, we incorporated the EAS into two cognitive enhancement trials, one in- vestigating a computerized cognitive training intervention in nearly 100 older adults and another examining non-invasive brain stimulation in nearly 100 young adults. Both trials had a double-blind balanced-placebo design in which participants were assigned to the intervention or control condition, and then subdivided to receive ei- ther high or low expectation priming (i.e., primed to have high or low expectations of the program’s effectiveness). Although expectation ratings replicated our previous findings, results from these trials suggest little, if any, effect of either expectations or the intervention on performance outcomes. We nevertheless found that participants enjoyed their assigned program and that those who received high expectation prim- ing tended to report a more positive experience. Our findings put into question the effectiveness of such interventions and support the need for more rigorous trials of cognitive enhancement.

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by a resting tremor combined with varying degrees of rigidity and bradykinesia. Introduced in the 1950s, thalamotomy is used as a surgical procedure to improve brain function in patients and serves as an effective treatment method for the PD tremor where connections within the thalamus are cut. In 1987, deep brain stimulation (DBS), chronic electrical stimulation of deep neural structures using electrodes, was introduced as a clinical treatment for medically refractory tremor in patients with PD. Though thalamotomy has historically been the primary treatment method for PD, an increasing number of patients have chosen to undergo DBS as it has become increasingly touted as an alternative to ablative therapies. The proposed study examines the advantages and disadvantages of both treatment methods to improve cardinal features in highly-skilled, career-oriented PD patients who actively use motor functions in their work. As an alternative to a simple finger-tapping test used for normal PD patients, a more complex strength-dexterity (S-D) test would be performed on 50 skilled patients to evaluate and compare the effectiveness of tremor suppression between both surgeries. The goal of this experiment is to determine which treatment produces the most short-term benefits for the patient to continue with his or her career with minimal future management required. The results of this study will help determine the preferred treatment method when taking into consideration other external factors such as cost, continual management, and preference for short-term vs. long-term results.

Neurological disorders require varying types and degrees of treatments depending on the symptoms and underlying causes of the disease. Patients suffering from medication-refractory symptoms often undergo further treatment in the form of brain stimulation, e.g. electroconvulsive therapy (ECT), transcranial direct current stimulation (tDCS), deep brain stimulation (DBS), or transcranial magnetic stimulation (TMS). These treatments are popular and have been shown to relieve various symptoms for patients with neurological conditions. However, the underlying effects of the stimulation, and subsequently the causes of symptom-relief, are not very well understood. In particular, TMS is a non-invasive brain stimulation therapy which uses time-varying magnetic fields to induce electric fields on the conductive parts of the brain. TMS has been FDA-approved for treatment of major depressive disorder for patients refractory to medication, as well as symptoms of migraine. Studies have shown that TMS has relieved severe depressive symptoms, although researchers believe that it is the deeper regions of the brain which are responsible for symptom relief. Many experts theorize that cortical stimulation such as TMS causes brain signals to propagate from the cortex to these deep brain regions, after which the synapses of the excited neurons are changed in such a way as to cause plasticity. It has also been widely observed that stimulation of the cortex causes signal firing at the deeper regions of the brain. However, the particular mechanisms behind TMS-caused signal propagation are unknown and understudied. Due to the non-invasive nature of TMS, this is an area in which investigation can be of significant benefit to the clinical community. We posit that a deeper understanding of this phenomenon may allow clinicians to explore the use of TMS for treatment of various other neurological symptoms and conditions. This thesis project seeks to investigate the various effects of TMS in the human brain, with respect to brain tissue stimulation as well as the cellular effects at the level of neurons. We present novel models of motor neuron circuitry and fiber tracts that will aid in the development of deep brain stimulation modalities using non-invasive treatment paradigms.

Background: The birth of stereotactic functional neurosurgery in 1947 was to a great extent dependent on the development of ventriculography. The last decades have witnessed a renaissance of functional stereotactic neurosurgery in the treatment of patients with movement disorders. Initially, these procedures were largely based on the same imaging technique that had been used since the birth of this technique, and that is still used in some centers. The introduction of new imaging modalities such as Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) provided new potentials, but also new challenges for accurate identification and visualisation of the targets in the basal ganglia and the thalamus with an urge to thoroughly evaluate and optimize the stereotactic targeting technique, as well as evaluate accurately in stereotactic space the location and extent of stereotactic Radiofrequency (RF) lesions and the position of deep brain stimulation (DBS) electrodes. Aims: To study the differences between CT and MRI regarding indirect atlas coordinates in thalamic and pallidal procedures and to evaluate and validate visualisation of the pallidum and the subthalamic nucleus in view of direct targeting irrespective of atlas-derived coordinates. Furthermore, to evaluate the contribution of RF parameters on the size of stereotactic lesions, as well as the impact of size and location on clinical outcome. Method: The coordinates in relation to the landmarks of the 3rd ventricle of the targets in the pallidum and ventrolateral thalamus were compared between CT and MRI in 34 patients. In another 48 patients direct visualization  of the pallidum was evaluated and compared to indirect atlas based targeting. The possibility and versatility of visualizing the Subthalamic Nucleus (STN) on short acquisition MRI were evaluated in a multicentre study, and the use of alternative landmarks in identification of the STN was demonstrated in another study. In 46 patients CT and MRI were compared regarding the volume of the visible RF lesions. The volume was analysed with regard to coagulation parameters, and the location and size of the lesions were further evaluated concerning the clinical outcome. Results:Minor deviations were seen between MRI and  CT coordinates of brain targets. The rostro-caudal direction of these deviations were such that they would be easily accounted for during surgery, why MRI can obviate the need for CT in these procedures. MRI using a proton density sequence provided detailed images of the pallidal structures, which demonstrated considerable inter-individual variations in relation to the landmarks of the 3rd ventricle. By using a direct visualization of the target, each patient will act as his or her own atlas, avoiding the uncertainties of atlas-based targeting. The STN could be visualized on various brands of MRI machines in 8 centers in 6 countries with good discrimination and with a short acquisition time, allowing direct visual targeting. The same scanning technique could be used for postoperative localization of the implanted electrodes. In cases where the lateral and inferior borders of the STN cannot be easily distinguished on MRI the Sukeroku sign and the dent internal-capsule-sign signs might be useful. The volume of a stereotactic RF lesion could be as accurately assessed by CT as by MRI. The lesion´s size was most strongly influenced by the temperature used for coagulation. The lesions´ volumes were however rather scattered and difficult to predict in the individual patient based solely on the coagulation parameters. For thalamotomy, the results on tremor was not related to the lesion´s volume. For pallidotomy, larger and more posterior-ventral lesions had better effect on akinesia while effects on tremor and dyskinesias were not related to size or location of the lesions. Conclusions: The minor deviations of MRI from CT coordinates can be accounted for during surgery, why MRI can obviate the need of CT in these procedures. Direct visualized targeting on MRI of the pallidum is superior to atlas based targeting. The targets in the pallidum and the STN, as well as the location of the electrodes, can be well visualized with short acquisition MRI. When borders of the STN are poorly defined on MRI the Sukeroku sign and the dent internal-capsule-sign signs proved to be useful. The volumes of RF lesions can be accurately assessed by both stereotactic thin slice CT and MRI. The size of these lesions is most strongly influenced by the temperature of coagulation, but difficult to predict in the individual patient based on the coagulation parameters. Within certain limits, there were no clear relationships between lesions´ volume and location and clinical effects of thalamotomies and pallidotomies.

The Deep Brain Stimulation (DBS) is an invasive therapy that alleviates the symptoms of several neurological disorders by electrically stimulating specific regions of the brain, generally within the basal ganglia. Until now Medtronic DBS system is the only approved by the Food and Drug Administration, nevertheless European and Australian countries  have recently approved St. Jude DBS systems to treat Parkinson’s disease and related movement disorders.      Traditionally, voltage-controlled stimulation (the type of systems provided by Medtronic) has been used and clinicians are familiar with its settings; however the knowledge about systems based in current-controlled stimulation (St. Jude systems) is rather scarce. One of the key factors for a successful therapy is the optimal selection of the electrical parameters for stimulation. Due to the critical zone where the surgery is performed, modeling and simulations of DBS systems have been extensively used to observe how the electric field is distributed in the brain tissue and ultimately to help the clinicians to select the best parameters.      In this thesis two finite element models of the DBS systems mentioned above have been developed; five examinations were designed, based on the physical and electrical differences between the systems, to observe and quantitatively compare the electric field distribution.     The aim of this thesis was to investigate the differences between two representative models of each company but moreover to contribute with information regarding current-controlled stimulation. The results obtained are expected to be useful for further investigations where the magnitude and distribution of the electric field generated by this type of electrodes are needed.

The in-vivo observation of the neural activities generated by a large number of closely located neurons is believed to be crucial for understanding the nervous system. Moreover, the functional electrical stimulation of the central nervous system is an effective method to restore physiological functions such as limb control, sound sensation, and light perception. The Deep Brain Stimulation (DBS) is being successfully used in the treatment of tremor and rigidity associated with advanced Parkinson's disease. Cochlear implants have also been employed as an effective treatment for sensorineural deafness by means of delivering the electrical stimulation directly to the auditory nerve. The most significant contribution of this PhD study is the development of next-generation microprobes for the simultaneous stimulation and recording of the cortex and deep brain structures. For intracortical applications, millimetre length multisite microprobes that are rigid enough to penetrate into the cortex while integrated with flexible interconnection cables are demanded. In chronic applications, the flexibility of the cable minimizes the tissue damage caused by the relative micro-motion between the brain and the microprobe. Although hybrid approaches have been reported to construct such neural microprobes, these devices are brittle and may impose severe complications if they break inside the tissue. In this project, MEMS fabrication processes were employed to produce non-breakable intracortical microprobes with an improved structural design. These 32 channel devices are integrated with flexible interconnection cables and provide enough mechanical strength for penetration into the tissue. Polyimide-based flexible implants were successfully fabricated and locally reinforced at the tip with embedded 15 µm-thick gold micro-needles. In DBS applications, centimetre long microprobes capable of stimulating and recording the neural activity are required. The currently available DBS probes, manufactured by Medtronic, provide only four cylindrical shaped electrode sites, each 1.5 mm in height and 1.27 mm in diameter. Although suitable for the stimulation of a large brain volume, to measure the activity of a single neuron but to avoid measuring the average response of adjacent cells, recording sites with dimensions in the range of 10 - 20 µm are required. In this work, novel Three Dimensional (3D) multi channel microprobes were fabricated offering 32 independent stimulation and recording electrodes around the shaft of the implant. These microprobes can control the spatial distribution of the charge injected into the tissue to enhance the efficacy and minimize the adverse effects of the DBS treatment. Furthermore, the device volume has been reduced to one third the volume of a conventional Medtronic DBS lead to significantly decrease the tissue damage induced by implantation of the microprobe. For both DBS and intracortical microprobes, the impedance characteristics of the electrodes were studied in acidic and saline solutions. To reduce the channel impedance and enhance the signal to noise ratio, iridium (Ir) was electroplated on gold electrode sites. Stable electrical characteristics were demonstrated for the Ir and gold electrodes over the course of a prolonged pulse stress test for 100 million cycles. The functionality and application potential of the fabricated microprobes were confirmed by the in-vitro measurements of the neural activity in the mouse hippocampus. In order to reduce the number of channels and simplify the signal processing circuitry, multiport electrostatic-actuated switch matrices were successfully developed, fabricated, and characterized for possible integration with neural microprobes to construct a site selection matrix. Magnetic-actuated switches have been also investigated to improve the operation reliability of the MEMS switching devices.